Literature DB >> 1710525

Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.

T B McCall1, M Feelisch, R M Palmer, S Moncada.   

Abstract

1. The synthesis of nitric oxide (NO) from L-arginine by rat peritoneal neutrophils (PMN) and the murine macrophage cell-line J774 and the inhibition of this synthesis by N-iminoethyl-L-ornithine (L-NIO), NG-monomethyl-L-arginine (L-NMMA), NG-nitro-L-arginine (L-NNA) and its methyl ester (L-NAME) were investigated. 2. L-NIO was the most potent inhibitor in both types of cells while L-NMMA was less active. L-NNA and L-NAME had no significant effect in PMN and L-NNA produced only approximately 40% inhibition of the generation of NO in the J774 cells at the highest concentration tested (300 microM). 3. The inhibitory effect of L-NIO was rapid in onset, requiring 10 min pre-incubation to achieve its full inhibitory activity, while the other compounds required 20-60 min pre-incubation to achieve their full effect. 4. The inhibitory effect of L-NIO (10 microM) on intact cells could not be reversed by L-arginine (300 microM) but could be prevented by concomitant incubation with this compound (300 microM), while the effect of the other inhibitors could be reversed by a 3-5 fold molar excess of L-arginine. 5. The NO synthase from both PMN and J774 cells was cytosolic and NADPH- but not Ca2(+)-dependent, with Km values for L-arginine of 3.3 +/- 0.8 and 4.2 +/- 1.1 microM respectively. 6. L-NIO was the most potent inhibitor of the neutrophil and J774 enzymes with IC50 values of 0.8 +/- 0.1 and 3 +/- 0.5 microM respectively. Furthermore, the effect of L-NIO was irreversible. The other three compounds were less potent, reversible inhibitors. 7. The inhibitory effects of all these compounds were enantiomerically specific. 8. These data indicate that L-NIO is a novel, potent, rapid in onset and irreversible inhibitor of NO synthase in phagocytic cells. The rapid uptake of L-NIO compared with the other compounds indicates that phagocytic cells have different uptake mechanisms for L-arginine analogues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710525      PMCID: PMC1917886          DOI: 10.1111/j.1476-5381.1991.tb12159.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages.

Authors:  N S Kwon; C F Nathan; D J Stuehr
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

2.  Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor.

Authors:  M A Tayeh; M A Marletta
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

3.  Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.

Authors:  D Salvemini; G de Nucci; R J Gryglewski; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

8.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.

Authors:  J B Hibbs; Z Vavrin; R R Taintor
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

9.  Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands.

Authors:  M Palacios; R G Knowles; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

10.  Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide.

Authors:  D J Stuehr; S S Gross; I Sakuma; R Levi; C F Nathan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  58 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  A perfusion system for the long term study of macrophage activation.

Authors:  J Assreuy; S Moncada
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

3.  2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo.

Authors:  W S Faraci; A A Nagel; K A Verdries; L A Vincent; H Xu; L E Nichols; J M Labasi; E D Salter; E R Pettipher
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Central control of blood pressure by nitrergic mechanisms in organum vasculosum laminae terminalis of rat brain.

Authors:  M T Lin; S P Pan; J H Lin; Y L Yang
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation.

Authors:  Mercedes Vázquez-Chantada; Usue Ariz; Marta Varela-Rey; Nieves Embade; Nuria Martínez-Lopez; David Fernández-Ramos; Laura Gómez-Santos; Santiago Lamas; Shelly C Lu; M Luz Martínez-Chantar; José M Mato
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 6.  Nitric oxide as a modulator of intestinal water and electrolyte transport.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

7.  Role of nitric oxide in prevention of ethanol-induced gastric damage by CuNSN a copper-chelating compound.

Authors:  L Franco
Journal:  Inflamm Res       Date:  1995-01       Impact factor: 4.575

Review 8.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

9.  Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin.

Authors:  M M Teixeira; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 10.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.